Investors NYSE AMERICAN: LCTX Data Provided by Refinitiv. Minimum 15 minutes delayed. VIEW STOCK QUOTE Press Releases November 29, 2022 Lineage to Present at BTIG Ophthalmology Day and the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference November 28, 2022 Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration November 10, 2022 Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update VIEW PRESS RELEASES Events & Presentations Lineage Cell Therapeutics Corporate Overview January 23, 2023 5.4 MB Roche’s Pharma Day 2022 Third Quarter 2022 Financial Results Earnings Call Nov 10, 2022 at 4:30 PM EST Click here for webcast VIEW EVENTS & PRESENTATIONS
November 29, 2022 Lineage to Present at BTIG Ophthalmology Day and the Cantor Fitzgerald Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference
November 28, 2022 Lineage Announces Launch of Phase 2a Study by Genentech of RG6501 (OpRegen®) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
November 10, 2022 Lineage Cell Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Third Quarter 2022 Financial Results Earnings Call Nov 10, 2022 at 4:30 PM EST Click here for webcast
